Artiva Biotherapeutics, Inc. (ARTV) earnings
ARTV earnings moved a median of +0.46% by the close. Quarterly and annual ARTV reports and results, each read against the price at its own news timestamp. Back to the ARTV overview →
17 measured ARTV earnings events.
Where these ARTV earnings landedvs 17 measured ARTV earnings reactions
| Middle 50% of ARTV earnings reactions | -5.38% to +6.26% |
|---|---|
| Median reaction (to close) | +0.46% |
| Measured reactions | 17 |
Point-in-time · zero look-ahead
Half of the 17 ARTV earnings events with a measured close landed between -5.38% and +6.26%; 53% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Artiva Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights | Press release | +0.63% | -1.14% | |
| Form 10-Q Artiva Biotherapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.63% | -1.14% | |
| Artiva Biotherapeutics Reports First Quarter 2026 Financial Results and Recent Business Highlights | Press release | -3.60% | -10.00% | |
| Form 10-Q Artiva Biotherapeutics, For: Mar 31 | SEC filing · Form 10-Q | -3.60% | -10.00% | |
| Form 10-K/A Artiva Biotherapeutics, For: Dec 31 | SEC filing · Form 10-K | -1.03% | +5.57% | |
| Form 10-K Artiva Biotherapeutics, For: Dec 31 | SEC filing · Form 10-K | -0.33% | +16.50% | |
| Artiva Biotherapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights | Press release | +3.06% | +10.86% | |
| Form 10-Q Artiva Biotherapeutics, For: Sep 30 | SEC filing · Form 10-Q | +3.06% | +10.86% | |
| Artiva Biotherapeutics Reports Second Quarter 2025 Financial Results, Recent Business Highlights | Press release | +4.66% | -5.38% | |
| Form 10-Q Artiva Biotherapeutics, For: Jun 30 | SEC filing · Form 10-Q | +4.66% | -5.38% | |
| Artiva Biotherapeutics Reports First Quarter 2025 Financial Results, Recent Business Highlights | Press release | -2.30% | +0.46% | |
| Form 10-Q Artiva Biotherapeutics, For: Mar 31 | SEC filing · Form 10-Q | -2.30% | +0.46% | |
| Form 10-K Artiva Biotherapeutics, For: Dec 31 | SEC filing · Form 10-K | +1.81% | +3.10% | |
| Artiva Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights | Press release | +0.00% | -11.77% | |
| Form 10-Q Artiva Biotherapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -11.77% | |
| Artiva Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights | Press release | -0.09% | +6.26% | |
| Form 10-Q Artiva Biotherapeutics, For: Jun 30 | SEC filing · Form 10-Q | -0.09% | +6.26% |
Keep exploring
More ARTV: analyst actions → · SEC filings → · ARTV overview →